Ubs Oconnor LLC Synlogic, Inc. Transaction History

Ubs Oconnor LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.42 - $0.68 $255,458 - $413,599	608,234 New	608,234 $262 Million
Q4 2022 Feb 14, 2023	BUY	$0.58 - $17.99 $98,351 - $3.05 Million	169,571 Added 36.41%	635,312 $0
Q3 2022 Nov 14, 2022	SELL	$0.91 - $14.63 $70,201 - $1.13 Million	-77,144 Reduced 14.21%	465,741 $442 Million
Q2 2022 Aug 12, 2022	BUY	$0.89 - $2.47 $157,890 - $438,190	177,405 Added 48.54%	542,885 $624,000
Q1 2022 May 16, 2022	BUY	$1.63 - $2.55 $595,732 - $931,973	365,480 New	365,480 $877,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $105M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.